HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

GW420867

Also Known As:

(S)-3-ethyl-6-fluoro-4-isoproxycarbonyl-3,4-dihydro-quinoxaline-2(1H)-one; GW 420867; HBY 1293A

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Quinoxalines: 324
      - GW420867: 1

Experts

1.	Ansari, A A: 1 article (07/2000)
2.	Heeney, J L: 1 article (07/2000)
3.	Mori, K: 1 article (07/2000)
4.	Rosenwith, B: 1 article (07/2000)
5.	Rübsamen-Waigmann, H: 1 article (07/2000)
6.	Sawada, S: 1 article (07/2000)
7.	Sugama, K: 1 article (07/2000)
8.	Uberla, K: 1 article (07/2000)
9.	Villinger, F: 1 article (07/2000)
10.	Yamazaki, S: 1 article (07/2000)

Related Diseases

1.	Viremia 07/01/2000 - "Suppression of acute viremia by short-term postexposure prophylaxis of simian/human immunodeficiency virus SHIV-RT-infected monkeys with a novel reverse transcriptase inhibitor (GW420867) allows for development of potent antiviral immune responses resulting in efficient containment of infection."
2.	Infections 07/01/2000 - "Suppression of acute viremia by short-term postexposure prophylaxis of simian/human immunodeficiency virus SHIV-RT-infected monkeys with a novel reverse transcriptase inhibitor (GW420867) allows for development of potent antiviral immune responses resulting in efficient containment of infection."

Related Drugs and Biologics

1.	Reverse Transcriptase Inhibitors
2.	Antiviral Agents (Antivirals)